Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Immune cell surface markers play a central role in defining immune cell identity, activation status, and functional states across both basic immunology and translational research. Recombinant proteins corresponding to these markers are essential tools for immune phenotyping, antibody development, and cell-based functional assays.
Our Immune Cell Surface Marker recombinant protein portfolio is designed to support reproducible and application-ready immune research, with careful attention to protein design, expression systems, and quality control strategies aligned with downstream experimental use.
Immune cell surface marker proteins are widely applied across diverse experimental workflows. This portfolio is developed to address common research needs in immunology, oncology, and immunotherapy development.
Immune Cell Phenotyping and Subset Identification
Recombinant surface marker proteins are routinely used in flow cytometry–based assay development, antibody validation, and immune cell subset characterization, enabling accurate discrimination of immune populations and activation states.
Immune Activation and Exhaustion Studies
Surface markers associated with immune activation, co-stimulation, and exhaustion are critical for evaluating immune responses under physiological and pathological conditions, including chronic infection, inflammation, and tumor microenvironments.
Antibody Discovery and Validation
Immune cell surface markers serve as essential antigens for antibody screening, affinity assessment, and specificity validation, supporting the development of research and preclinical antibodies.
Cell-Based Functional Assays
These proteins are suitable for use in receptor–ligand interaction studies, signaling pathway analysis, and assay calibration in cell-based experimental systems.
Immunotherapy and Translational Research
Surface marker proteins are widely applied in the evaluation of immunotherapy targets, including immune checkpoint–related studies, CAR and TCR research workflows, and target feasibility assessments.
The portfolio encompasses immune cell surface markers expressed across multiple immune lineages and functional states, including:
This broad coverage enables flexible selection of targets to support diverse experimental designs and immune research objectives.
To ensure experimental reliability, immune cell surface marker proteins are designed with an emphasis on native-like structure and functional integrity. Constructs are selected to preserve biologically relevant domains, supporting accurate molecular interactions in downstream applications.
Appropriate expression systems are employed to facilitate correct protein folding, post-translational modifications, and structural stability, particularly for proteins requiring complex conformational or glycosylation features.
Consistent product quality is essential for immune research workflows. Each recombinant protein is produced and evaluated under standardized quality control processes designed to support experimental reproducibility.
Key quality attributes include:
These measures help ensure reliable performance across a range of immunological applications.
Immune cell surface marker recombinant proteins are suitable for use in a wide range of research applications, including:
To accommodate diverse research requirements, the portfolio supports flexible options across target selection and experimental design. Proteins are supplied for research use only and are produced to meet the needs of discovery-stage and preclinical research programs.
For detailed product information, technical specifications, or application guidance, please explore individual product pages or contact our technical support team.
| Cat.No. | Product Name | Price |
|---|---|---|
| RP00002 | Recombinant Human CD7 (C-6His) | Inquiry |
| RP00004 | Recombinant Human CD27 (C-Fc-6His) | Inquiry |
| RP00005 | Recombinant Mouse SIRPA (C-Fc) | Inquiry |
| RP00007 | Recombinant Mouse CD24 (C-Fc) | Inquiry |
| RP00008 | Recombinant Human CD38 (C-Fc) | Inquiry |
| RP00016 | Recombinant Human SIRPA (C-Fc) | Inquiry |
| RP00021 | Recombinant Human CD40 (C-6His) | Inquiry |
| RP00025 | Recombinant Human SIRPA (C-mIgG2aFc) | Inquiry |
| RP00033 | Recombinant Human CD38 (C-6His) | Inquiry |
| RP00034 | Recombinant Human CD38 (N-6His) | Inquiry |
| RP00038 | Recombinant Human SIRPA (C-6His) | Inquiry |
| RP00039 | Recombinant Human CD79B (C-6His) | Inquiry |
| RP00044 | Recombinant Human CD19 (C-Fc) | Inquiry |
| RP00049 | Recombinant Human CD37 (C-Fc) | Inquiry |
| RP00069 | Recombinant Mouse CD52 (C-Fc) | Inquiry |
Copyright © Creative Biogene. All rights reserved.